Furthermore, in an investigation of the role of S100P in pancreatic cancer, one study revealed that cells with siRNA-silenced S100P expression grew at a significantly reduced rate compared with control siRNA-expressing cells [23]. This evidence concerns the gene S100P and pancreatic neoplasm.